Sentences with phrase «member of the vaccine development»

Not exact matches

La Montagne chaired the World Health Organization Task Force on Strategic Planning for the Children's Vaccine Initiative, advised the Pan American Health Organization on programs for vaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug DevelVaccine Initiative, advised the Pan American Health Organization on programs for vaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug Develvaccine - research implementation, and served as a member of the board for the Global Alliance for Tuberculosis Drug Development.

Jury member Penny Heaton, director of vaccine development at the Bill & Melinda Gates Foundation, said CureVac's RNA technology had «the potential for a large and positive impact on public health,» in a statement released by the company on 10 March.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

Members of the CSCB also collaborate on a variety of projects related to detecting, understanding and treating cancer, other diseases and clinical disorders, as well as projects on infectious disease and the development of new and more effective vaccines.

As a member of the Vaccine & Immunotherapy Center he studied accelerated vaccine development and targeted cancer therapies until FebruarVaccine & Immunotherapy Center he studied accelerated vaccine development and targeted cancer therapies until Februarvaccine development and targeted cancer therapies until February 2015.

The stock ran on the news, prompting VXGN to clarify yesterday that it «retains an option to obtain the exclusive right to manufacture, commercialize, and further develop the HIV vaccine candidates in the U.S., Europe, Japan and other countries that are members of the Organization of Economic Cooperation and Development» but «has no rights or obligations to manufacture or develop the vaccine candidates unless and until it exercises this option.»